Acute Radiation Esophagitis Caused by High-Dose Involved Field Radiotherapy with Concurrent Cisplatin and Vinorelbine for Stage III Non-small Cell Lung Cancer

Yuuki Kuroda(Yamagata University), Jun Itami(National Cancer Centre Japan), Shuhei Sekii(Tokyo National Hospital), Hiroshi Nokihara(Tokushima University Hospital), Noboru Yamamoto(Tokyo National Hospital), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Koji Inaba(National Cancer Center), Ikuo Sekine(University of Tsukuba), Hiroshi Mayahara, Hidehito Horinouchi(Tokyo National Hospital), Naoya Murakami(Tokushima University Hospital), Kaoru Kubota(Nippon Medical School Hospital), Yoshinori Ito(National Cancer Center Hospital East), Kenji Nemoto(Yamagata University), Tomohide Tamura(St. Luke's International Hospital), Madoka Morota(Japanese Foundation For Cancer Research), Kana Takahashi(Nihon University)
Technology in Cancer Research & Treatment
January 30, 2013
10.7785/tcrt.2012.500319
Cited by 11

Related Papers

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2019|3.4k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600